SCHEMBL6302516

SCHEMBL6302516

CC(C)(C)OC(=O)N1CCN(C(=O)c2cc3nccc(Cl)c3s2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.52
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
GPR119 Q8TDV5 5/20 0.45
SMYD3 Q9H7B4 1/20 0.43
CFTR P13569 1/20 0.42
STS P08842 1/20 0.41
DTYMK P23919 1/20 0.41
SCD5 Q86SK9 1/20 0.40
CNR1 P21554 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
SIRT3 Q9NTG7 1/20 0.39
DYRK2 Q92630 1/20 0.39
TP53 P04637 1/20 0.39
IDE P14735 1/20 0.39
ACHE P22303 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
STAT3 P40763 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2537201 0.84 KDM4E (0.50) POLBKMT2ATP53MAPT
SCHEMBL6302113 0.84 CLK1 (0.46) POLBMEN1KMT2ASMYD3TP53
Hydrochloric Acid SCHEMBL6998891 0.83 CLK1 (0.46) POLBMEN1KMT2ASMYD3TP53
SCHEMBL198195 0.82 TP53 (0.49) POLBMEN1KMT2ATP53MAPT
SCHEMBL307245 0.82 TP53 (0.52) POLBSIRT2SIRT1SIRT3TP53
SCHEMBL14860038 0.81 TP53 (0.54) POLBSIRT2SIRT1SIRT3TP53
SCHEMBL6302553 0.80 SIRT2 (0.40) CFTRSIRT2SIRT1SIRT3
SCHEMBL6310345 0.80 CFTR (0.48) CFTRSIRT2SIRT1SIRT3
SCHEMBL2206333 0.79 HPGD (0.51) TP53MAPTMAPK1SMN1; SMN2
SCHEMBL10224379 0.77 MAPT (0.45) POLBMEN1KMT2ASIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6964961-B2 Thiophene derivatives useful as anticancer agents PFIZER INC (US) 2005-11-15 US disclosed
EP-1287001-B1 THIOPHENE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER PROD INC (US) 2004-09-29 EP disclosed
EP-1287001-A1 THIOPHENE DERIVATIVES USEFUL AS ANTICANCER AGENTS Pfizer Products Inc. (US) 2003-03-05 EP disclosed
US-20020042409-A1 Thiophene derivatives useful as anticancer agents PFIZER PRODUCTS INC. 2002-04-11 US disclosed
WO-2001094353-A1 THIOPHENE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER PRODUCTS INC. (US) 2001-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042409-A1 Thiophene derivatives useful as anticancer agents TP53, RCC1, CCNA1 POLB 1768/4885MEN1 786/4885KMT2A 2831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.